Literature DB >> 8232900

Chandelier cell axons identified by parvalbumin-immunoreactivity in the normal human temporal cortex and in Alzheimer's disease.

M Fonseca1, E Soriano, I Ferrer, A Martinez, T Tuñon.   

Abstract

Parvalbumin is a calcium-binding protein which is thought to play a role in neuronal excitability. In the cerebral cortex parvalbumin is largely found in two subsets of GABAergic neurons, the chandelier and basket cells. A distinguishing characteristic of the chandelier cell is that the terminal portions of its axon form short vertical strings of boutons resembling candlesticks, which embrace the initial segment of pyramidal cell axon. In the present study, the terminals of chandelier cells in the human temporal cortex were immunostained with an antibody against parvalbumin. These terminals were found more abundantly in layers II and VI, less frequently in layers III and V, were hardly identified in layer IV, and absent in layer I. The relationship of parvalbumin-immunoreactive terminals and axon initial segments was further evidenced by re-sectioning identified rows of boutons into semithin sections. Electron microscopy of both temporal cortex and the somatosensory region of a biopsy sample revealed that these parvalbumin-positive boutons indeed form symmetric synaptic contacts on the axon initial segments of pyramidal cells. As part of an enquiry into the possibility that these specialized interneurons may be involved in degenerative neurological diseases, the temporal lobes from seven patients with Alzheimer's disease were immunostained for parvalbumin. As in the control brains, the specific terminal portions of chandelier cells were recognized and identified in the temporal cortex by parvalbumin-immunocytochemistry. No major difference from normal brains was found, excepting for a lower density of candlesticks (30-35%) in layer II-III. Since we showed in a previous study [Ferrer et al. (1991) J. neurol. Sci. 106, 135-141] that the number of parvalbumin-immunoreactive somata in the same Alzheimer's disease cases was not decreased, the observed reduction of terminals in layer II suggest that only the terminals of chandelier cells, but not the parent neurons, are decreased in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8232900     DOI: 10.1016/0306-4522(93)90324-9

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  13 in total

1.  Altered neuronal distribution of parvalbumin in anterior cingulate cortex of rabbits exposed in utero to cocaine.

Authors:  X H Wang; A O Jenkins; L Choi; E H Murphy
Journal:  Exp Brain Res       Date:  1996-12       Impact factor: 1.972

2.  Contingent vulnerability of entorhinal parvalbumin-containing neurons in Alzheimer's disease.

Authors:  A Solodkin; S D Veldhuizen; G W Van Hoesen
Journal:  J Neurosci       Date:  1996-05-15       Impact factor: 6.167

3.  Hippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer's disease.

Authors:  Hisaaki Takahashi; Ivona Brasnjevic; Bart P F Rutten; Nicolien Van Der Kolk; Daniel P Perl; Constantin Bouras; Harry W M Steinbusch; Christoph Schmitz; Patrick R Hof; Dara L Dickstein
Journal:  Brain Struct Funct       Date:  2010-03-07       Impact factor: 3.270

4.  Timing of cortical interneuron migration is influenced by the cortical hem.

Authors:  Giuliana Caronia-Brown; Elizabeth A Grove
Journal:  Cereb Cortex       Date:  2010-08-16       Impact factor: 5.357

5.  Subpopulations of neurons expressing parvalbumin in the human amygdala.

Authors:  Harry Pantazopoulos; Nicholas Lange; Linda Hassinger; Sabina Berretta
Journal:  J Comp Neurol       Date:  2006-06-10       Impact factor: 3.215

6.  Differential distribution of inhibitory neuron types in subregions of claustrum and dorsal endopiriform nucleus of the short-tailed fruit bat.

Authors:  Timothy Morello; Richard Kollmar; Abdessamad Ramzaoui; Mark Stewart; Rena Orman
Journal:  Brain Struct Funct       Date:  2022-02-21       Impact factor: 3.270

7.  Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability.

Authors:  Martijn C de Wilde; Cassia R Overk; John W Sijben; Eliezer Masliah
Journal:  Alzheimers Dement       Date:  2016-01-14       Impact factor: 21.566

8.  Reduced secretagogin expression in the hippocampus of P301L tau transgenic mice.

Authors:  Johannes Attems; Arne Ittner; Kurt Jellinger; Roger M Nitsch; Magdalena Maj; Ludwig Wagner; Jürgen Götz; Mathias Heikenwalder
Journal:  J Neural Transm (Vienna)       Date:  2011-03-26       Impact factor: 3.575

9.  Pericellular innervation of neurons expressing abnormally hyperphosphorylated tau in the hippocampal formation of Alzheimer's disease patients.

Authors:  Lidia Blazquez-Llorca; Virginia Garcia-Marin; Javier Defelipe
Journal:  Front Neuroanat       Date:  2010-06-24       Impact factor: 3.856

10.  Diminished perisomatic GABAergic terminals on cortical neurons adjacent to amyloid plaques.

Authors:  Virginia Garcia-Marin; Lidia Blazquez-Llorca; José-Rodrigo Rodriguez; Susana Boluda; Gerard Muntane; Isidro Ferrer; Javier Defelipe
Journal:  Front Neuroanat       Date:  2009-11-20       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.